Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis

The present invention relates to the use of a photosensitiser which is 5-ALA or a precursor or derivative thereof (e.g. an ALA ester), in the manufacture of a pharmaceutical product for use in the photodynamic treatment or diagnosis of cancer, an infection associated with cancer, or in the treatment...

Full description

Saved in:
Bibliographic Details
Main Authors STENSRUD, Gry, GODAL, Aslak, KLAVENESS, Jo, KLEM, Bjorn, BRAENDEN, Jon
Format Patent
LanguageEnglish
Published 27.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the use of a photosensitiser which is 5-ALA or a precursor or derivative thereof (e.g. an ALA ester), in the manufacture of a pharmaceutical product for use in the photodynamic treatment or diagnosis of cancer, an infection associated with cancer, or in the treatment or diagnosis of a non-cancerous condition, wherein said pharmaceutical product is in the form of a solid. The invention also relates to solid pharmaceutical products for use in such methods, e.g. suppositories, pessaries, tablets, pellets and capsules which comprise 5-ALA or a precursor or derivative thereof (e.g. an ALA ester) and at least one pharmaceutically acceptable carrier or excipient. Such products are particularly suitable for use in the photodynamic treatment or diagnosis of cancerous or non- cancerous conditions in the lower part of the gastrointestinal system or in the female reproductive system, e.g. in the treatment or diagnosis of colorectal cancer or cervical cancer.
Bibliography:Application Number: AU20140200004